MII IG Kerndatensatz-Modul Molekulargenetischer Befundbericht
2027.0.0-ballot.1 -
Germany
MII IG Kerndatensatz-Modul Molekulargenetischer Befundbericht
2027.0.0-ballot.1 -
Germany
This page is part of the MII IG Kerndatensatz-Modul Molekulargenetischer Befundbericht (v2027.0.0-ballot.1: Release) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Language: en
Bundle mii-exa-befund-bundle-befund-fgfr2-fusion of type transaction
Entry 1 - fullUrl = https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-patient-fgfr2-fusion
Resource Patient:
Language: en
Anonymous Patient Female, DoB: 1964-05 ( pseudonymized (use: usual, ))
Deceased: false Contact Detail 10 DE
Request:
PUT Patient/mii-exa-molgen-patient-fgfr2-fusion
Entry 2 - fullUrl = https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-practitioner-lab
Resource Practitioner:
Language: en
active: true
name: Dr. Daniel Schmidt(Official)
Request:
PUT Practitioner/mii-exa-molgen-practitioner-lab
Entry 3 - fullUrl = https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-practitioner-physician
Resource Practitioner:
Language: en
active: true
name: Dr. Linda Rubens(Official)
Request:
PUT Practitioner/mii-exa-molgen-practitioner-physician
Entry 4 - fullUrl = https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-befundbericht-fgfr2-fusion
Resource DiagnosticReport:
Language: en
Profiles: MII PR MolGen Molekulargenetischer Befundbericht version: 2027.0.0-ballot.1, Genomic Report version: 3.0.0
Genetic analysis report (Genetics)
Subject Anonymous Patient Female, DoB: 1964-05 ( pseudonymized (use: usual, )) Performer Practitioner Dr. Daniel Schmidt(official) Report Details
Code Value Flags Relevant Time Diagnostic Implication Final 2022-11-30 Genetic variant assessment Present Final 2022-11-30 Therapeutic Implication Final 2022-11-30 Nachweis FGFR2-Fusion. Empfehlung: Hochselektive FGFR-Inhibitor-Therapie.
Request:
PUT DiagnosticReport/mii-exa-molgen-befundbericht-fgfr2-fusion
Entry 5 - fullUrl = https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-anforderung-fgfr2-fusion
Resource ServiceRequest:
Language: en
Profile: MII PR MolGen Anforderung genetischer Test version: 2027.0.0-ballot.1
identifier:
https://www.charite.de/fhir/auftragsnummern/PRK4QE59Astatus: Active
intent: Order
category: Laboratory procedure (procedure)
code: No display for ServiceRequest.code (concept: Molecular genetic test (procedure))
subject: Anonymous Patient Female, DoB: 1964-05 ( pseudonymized (use: usual, ))
authoredOn: 2022-11-30
requester: Practitioner Dr. Linda Rubens(official)
Request:
PUT ServiceRequest/mii-exa-molgen-anforderung-fgfr2-fusion
Entry 6 - fullUrl = https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-variante-fgfr2-fusion
Resource Observation:
Language: en
Profiles: MII PR MolGen Variante version: 2027.0.0-ballot.1, Variant version: 3.0.0
basedOn: ServiceRequest Molecular genetic test (procedure)
status: Final
category: Laboratory, Genetics
code: Genetic variant assessment
subject: Anonymous Patient Female, DoB: 1964-05 ( pseudonymized (use: usual, ))
effective: 2022-11-30
value: Present
method: Sequencing
component
code: Gene studied [ID]
value: FGFR2
component
code: DNA change type
value: gene_fusion
component
code: Gene fusion transcript details in Blood or Tissue by Molecular genetics method Narrative
value: FGFR2::DBP
Request:
PUT Observation/mii-exa-molgen-variante-fgfr2-fusion
Entry 7 - fullUrl = https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion
Resource Observation:
Language: en
Profiles: MII PR MolGen Diagnostische Implikation version: 2027.0.0-ballot.1, Diagnostic Implication version: 3.0.0
status: Final
category: Laboratory, Genetics
code: Diagnostic Implication
subject: Anonymous Patient Female, DoB: 1964-05 ( pseudonymized (use: usual, ))
effective: 2022-11-30
performer: Practitioner Dr. Daniel Schmidt(official)
derivedFrom: Observation Genetic variant assessment
Components
Code Value[x] Conclusion Text starke Überexpression (25-fach)
Request:
PUT Observation/mii-exa-molgen-diagnostische-implikation-fgfr2-fusion
Entry 8 - fullUrl = https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion
Resource Observation:
Language: en
Profiles: MII PR MolGen Therapeutische Implikation version: 2027.0.0-ballot.1, Therapeutic Implication version: 3.0.0
status: Final
category: Laboratory, Genetics
code: Therapeutic Implication
subject: Anonymous Patient Female, DoB: 1964-05 ( pseudonymized (use: usual, ))
effective: 2022-11-30
performer: Practitioner Dr. Daniel Schmidt(official)
derivedFrom: Observation Genetic variant assessment
component
code: Conclusion Text
value: Hochselektiver FGFR2-Inhibitor RLY-4008 bei Patienten mit Cholangiokarzinomen und anderen soliden Tumoren, mit oder ohne FGFR- gerichtete Vortherapie.
component
code: Medication assessed [ID]
value: Fibroblasten-Wachstumsfaktor-Rezeptor (FGFR)-Tyrosinkinase-Inhibitoren
component
code: Level of evidence
value: m1c
component
code: Associated phenotype
value: Intrahepatic bile duct carcinoma (disorder)
Request:
PUT Observation/mii-exa-molgen-therapeutische-implikation-fgfr2-fusion
Entry 9 - fullUrl = https://www.medizininformatik-initiative.de/fhir/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion
Resource Task:
Language: en
Profiles: MII PR MolGen Medikationsempfehlung version: 2027.0.0-ballot.1, Medication Recommendation version: 3.0.0
basedOn: ServiceRequest Molecular genetic test (procedure)
status: Requested
intent: Proposal
code: Hochselektive FGFR-Inhibitor-Therapie
for: Anonymous Patient Female, DoB: 1964-05 ( pseudonymized (use: usual, ))
Request:
PUT Task/mii-exa-molgen-medikationsempfehlung-fgfr2-fusion